Company profile for Advanz Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Advanz Pharma is a global pharmaceutical company that’s committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality, niche, established medicines. We do this by revitalising and innovating niche, established medicines that without our focus, may otherwise not be available to patients. Over the many years we have been supplying medicines, we have built a comm...
Advanz Pharma is a global pharmaceutical company that’s committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality, niche, established medicines. We do this by revitalising and innovating niche, established medicines that without our focus, may otherwise not be available to patients. Over the many years we have been supplying medicines, we have built a commercial platform across over 90 countries, providing a portfolio of over 200 niche established medicines safely and effectively.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
11-15 Seaton Place St Helier Jersey JE4 0QH
Telephone
Telephone
+44 (0) 208 588 9100
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-20/alvotech-and-advanz-pharma-receive-marketing-approval-across-the-european-economic-area-for-gobivaz-a-first-in-market-biosimilar-to-simponi-golimu

PHARMIWEB
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182645/0/en/Alvotech-and-Advanz-Pharma-Receive-Marketing-Authorisations-for-Gobivaz-a-Biosimilar-to-Simponi-golimumab-from-the-MHRA.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/06/3161486/0/en/European-Marketing-Application-for-AVT23-a-Proposed-Biosimilar-to-Xolair-omalizumab-Accepted-by-the-European-Medicines-Agency.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/09/22/3153691/0/en/European-Medicines-Agency-Recommends-Marketing-Approval-of-Gobivaz-Alvotech-s-Proposed-Biosimilar-to-Simponi-golimumab-with-Advanz-Pharma-as-Commercialization-Partner.html

GLOBENEWSWIRE
22 Sep 2025

https://www.globenewswire.com/news-release/2025/08/21/3136921/0/en/Advanz-Pharma-and-Alvotech-receive-European-approval-for-Mynzepli-Biosimilar-to-Eylea.html

GLOBENEWSWIRE
21 Aug 2025

https://www.contractpharma.com/breaking-news/advanz-pharma-alvotech-gain-european-approval-for-mynzepli/

CONTRACTPHARMA
21 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty